A model of intra-tumor and inter-patient heterogeneity explains clinical trials of curative combination therapy for lymphoma
{{output}}
Models of tumor drug response have illuminated important concepts in oncology, but there remains a need for theory that combines intra-tumor and inter-patient heterogeneity to explain patient outcomes, especially for curative treatments. We present a mathemati... ...